41 results on '"Uharek, L."'
Search Results
2. Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)
3. Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection
4. Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial
5. Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
6. Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning
7. Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines
8. Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion
9. Prophylactic i.v. Igs in patients with a high risk for CMV after allo-SCT
10. Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy
11. Serotherapy with thymoglobulin and alemtuzumab differentially influences frequency and function of natural killer cells after allogeneic stem cell transplantation
12. Intensified Strategies to Control Vancomycin-Resistant Enterococci in Immunocompromised Patients
13. Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma
14. Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation
15. Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease
16. CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets
17. BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning
18. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model
19. Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation
20. Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice
21. Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in mice
22. Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery
23. Investigating the lysis of small-cell lung cancer cell lines by activated natural killer (NK) cells with a fluorometric assay for NK-cell-mediated cytotoxicity
24. Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis
25. Use of natural killer cells in hematopoetic stem cell transplantation
26. Gaft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease
27. Ifosfamide and ACNU in experimental allogeneic bone marrow transplantation
28. Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukaemia effect in mice
29. Immunoglobulin receptor evolution in follicular lymphoma and a review of literature.
30. Allogeneic hematopoietic cell transplantation following conditioning with 90 Y-ibritumomab-tiuxetan.
31. CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.
32. BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.
33. High-dose cytostatic agents in allogeneic bone marrow transplantation: comparison of the engraftment promoting potential.
34. Mitoxantrone, Etoposide and Prednisolone (NOVEP) in Previously Untreated Elderly Patients with Non-Hodgkin's Lymphoma (NHL) and as Salvage Therapy for Refractory NHL.
35. Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
36. A new HLA-B*52 allele, B*52:23, detected in a patient before bone marrow transplantation.
37. Advances in clinical NK cell studies: Donor selection, manufacturing and quality control.
38. Detection of a novel HLA-A allele, designated A*02:334.
39. P266 - Murine DSS colitis as model for exploring mesenchymal stem cell therapy in inflammatory bowel disease.
40. Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma
41. Comparison of Cyclophosphamide, Cytarabine, and Etoposide as Immunosuppressive Agents Before Allogeneic Bone Marrow Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.